BWM
ABBV icon

BAM Wealth Management’s AbbVie ABBV Stock Holding History

BAM Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
1,349
+362
+37% +$77.9K 0.21% 124
2026
Q1 		$215K Buy
987
+53
+6% +$11.8K 0.16% 146
2025
Q4 		$213K Buy
+934
New +$213K 0.15% 147

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BAM Wealth Management's ABBV Position: Q2 2026 in Review

BAM Wealth Management increased its AbbVie (ABBV) stake by 37% in Q2 2026, buying an estimated $77.9K and bringing the position to 1,349 shares worth $339K. The position accounts for 0.21% of the portfolio, ranked #124.

BAM Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BAM Wealth Management held 1,349 shares of AbbVie worth $339K as of Q2 2026.
  • BAM Wealth Management bought 362 AbbVie shares in Q2 2026, an estimated $77.9K.
  • AbbVie made up 0.21% of BAM Wealth Management's portfolio in Q2 2026, its #124 holding.
  • BAM Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BAM Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.